Rac1 overexpression in SKOV-3 (ovary cancer) and ASG (gastric cancer) increased its IC50 dose to DDP treatment, whereas NSC23766 decreased the IC50 doses in these cells (Supplementary Fig. 3G, H). This evidence concerns the gene RAC1 and ovarian cancer.